Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances ; volume:15 ; number:1 ; day:29 ; month:5 ; year:2020 ; pages:1-22 ; date:12.2020
Molecular neurodegeneration ; 15, Heft 1 (29.5.2020), 1-22, 12.2020
- Creator
-
Wang, Wenzhang
Zhao, Fanpeng
Ma, Xiaopin
Perry, George
Zhu, Xiongwei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-020-00376-6
- URN
-
urn:nbn:de:101:1-2020080214290785667587
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Wenzhang
- Zhao, Fanpeng
- Ma, Xiaopin
- Perry, George
- Zhu, Xiongwei
- SpringerLink (Online service)
Other Objects (12)
Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer’s disease
Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling
The role of proteotoxic stress in vascular dysfunction in the pathogenesis of Alzheimer’s disease
Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis
Complement in the pathogenesis of Alzheimer’s disease
Advances in Alzheimer’s Disease Drug Development
Innate immunity and inflammation in Alzheimer´s disease pathogenesis
Dysfunction of NMDA receptors in Alzheimer’s disease
Advances in Drug Therapy for Alzheimer’s Disease
Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation
Correction to: Complement in the pathogenesis of Alzheimer’s disease
Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer’s disease
Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling
The role of proteotoxic stress in vascular dysfunction in the pathogenesis of Alzheimer’s disease
Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis
Complement in the pathogenesis of Alzheimer’s disease
Advances in Alzheimer’s Disease Drug Development
Innate immunity and inflammation in Alzheimer´s disease pathogenesis
Dysfunction of NMDA receptors in Alzheimer’s disease
Advances in Drug Therapy for Alzheimer’s Disease
Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation
Correction to: Complement in the pathogenesis of Alzheimer’s disease
Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer’s disease
Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling
The role of proteotoxic stress in vascular dysfunction in the pathogenesis of Alzheimer’s disease
Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis
Complement in the pathogenesis of Alzheimer’s disease
Advances in Alzheimer’s Disease Drug Development
Innate immunity and inflammation in Alzheimer´s disease pathogenesis
Dysfunction of NMDA receptors in Alzheimer’s disease
Advances in Drug Therapy for Alzheimer’s Disease
Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation